| Drug Class | Aminosalicylates |
|---|---|
| Mechanism | Release 5-aminosalicyclate acid in the bowel |
| Typical Dose | 2.4-4.8g OD |
| Indications | * Mild-moderate Ulcerative Colitis/Crohn’s * Maintenance of remission * RA |
| Contra-indications | * Salicylate hypersensitivity * Renal impairment |
| Side-effects | * GI disturbances * Headache * Arthralgia * Leucopenia |
| Interactions | No severe |
| Elimination | |
| Additional Notes | Renal impairment should be monitored for 3 months prior to starting treatment, and annually during treatment |